Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Drugs
Drugs
Page 11 of 29
Retail
Denmark’s Novo Nordisk forecasts 27% sales surge but faces price pressure amid Eli Lilly competition
By
Naomi Kresge
and
Bloomberg
May 2, 2024
Retail
Novo Nordisk’s market value of $570 billion is now bigger than the entire Danish economy—creating a ‘Nokia risk’ for Denmark
By
Sanne Wass
,
Naomi Kresge
and
Bloomberg
May 1, 2024
Politics
Biden’s DEA to reclassify marijuana in historic shift that still doesn’t decriminalize it, sources say
By
Zeke Miller
,
Joshua Goodman
,
Jim Mustian
,
Lindsay Whitehurst
and
The Associated Press
April 30, 2024
Politics
Frustrated by high drug prices, California will offer its own version of heavily discounted Narcan to stop fentanyl overdoses
By
Adam Beam
and
The Associated Press
April 29, 2024
Newsletters
AI for drug discovery draws a $1 billion launch—and a lot of hope
By
Sage Lazzaro
April 25, 2024
Retail
AstraZeneca encounters a surge in shares as profits exceed expectations, buoyed by demand for cancer drugs
By
Ashleigh Furlong
and
Bloomberg
April 25, 2024
Finance
Mexico’s meth trade has become so lucrative it is exporting the drugs as far away as Hong Kong and Australia
By
The Associated Press
April 24, 2024
Mind
Recreational cannabis use may lower your risk of cognitive decline, study says
By
Lindsey Leake
April 19, 2024
Lifestyle
‘It’s a phenomenon’: How 4/20 grew organically from a group of Northern California high schoolers into marijuana’s holiday
By
Gene Johnson
and
The Associated Press
April 19, 2024
Newsletters
Millions of Americans have used medical marijuana. Is it covered by their FSAs?
By
Emma Burleigh
April 19, 2024
How Medicare beneficiaries with Part D plans can help ensure their medications are covered
By
Richard Eisenberg
April 8, 2024
Health
ALS drug will be pulled from US market after study showed patients didn’t benefit
By
Matthew Perrone
and
The Associated Press
April 4, 2024
Politics
Oregon just officially changed its mind on decriminalizing drugs
By
The Associated Press
April 2, 2024
Health
Demand for weight-loss drug Zepbound is so strong that Eli Lilly is warning patients may leave pharmacies empty-handed
By
Ike Swetlitz
,
Madison Muller
and
Bloomberg
March 30, 2024
Retail
Walgreens’ frail quarter goes beyond the discretionary spending dips afflicting its competitors. It’s ‘just not very good at retailing,’ analyst says
By
Sasha Rogelberg
March 29, 2024
Most Popular
North America
Gates Foundation plans to give away $9 billion in 2026 to prepare for the 2045 closure while slashing hundreds of jobs
By
Sydney Lake
Economy
An unusual Fed ‘rate check’ triggered a free fall in the U.S. dollar and investors are fleeing into gold
By
Jim Edwards
Politics
Trump was surging after the Venezuela raid—then came Jerome Powell, Greenland, and Minnesota. Now it feels like a...
By
Jason Ma